A pilot project reveals that 84% of participants had a positive experience using a newly developed online tool created by the Alliance for Clinical Trials in Oncology called the Participant Engagement Portal. Alliance created PEP to foster direct connection between cancer researchers and the individuals who volunteer for clinical studies. The goal was to make it easier for patients and clinicians to share information, deliver trial updates, and self-report on social risk factors.
N-Power Medicine and New York Cancer & Blood Specialists announced a strategic partnership to accelerate the generation of N-Power’s Prospective External Control Arms. This approach is designed to reduce the size of oncology clinical trials and bring new therapies to patients years sooner.
